Profile of Potassium Serum in Coronary Heart Disease (CHD)

DOI

10.2991/978-94-6463-048-0_12How to use a DOI?

Keywords

Hyperkalemia; Hypokalemia; Heart Disease

Abstract

Potassium level is closely related to the prognosis in several phases of a disease, especially in cardiovascular disease. Severe hypokalemia causes arrhythmia leading to cardiac arrest. Therefore, it is necessary to monitor potassium levels in patients with cardiovascular disease. This study aims to assess the potassium profile in coronary heart disease patients who were hospitalized and outpatients. This research is a descriptive study. The data was collected from medical records of various cases of cardiovascular disease. The patients were taken from cardiac polyclinics and those hospitalized for cardiovascular disease, a total of 105 patients with a diagnosis of all cardiovascular diseases. Potassium levels were divided into three groups: hypokalemia with a potassium level of < 3.6 mEq/L, normal with a potassium level of 3.6 – 5.5 mEq/L, and hyperkalemia with a potassium level of > 5.5 mEq/L. Each classification of potassium level is then associated with the age and the diagnosis of the patient. The results of this study are 6.67% has potassium of < 3.6 mEq /L, 5.71% has potassium of > 5.5 mEq / L, and 87.62% has potassium of 3.6 - 5.5 mEq/L. Hypokalemia occurs predominantly in the arrhythmia diagnosis, NSTEMI (Non-ST-Elevation Myocard Infarct), and ventricular hypertrophy (28.57%). Hypokalemia is mostly recorded in those aged 56–60 years (42.85%). Hypokalemia is least recorded in those who were 56 years with a diagnosis of arrhythmia VES. Hyperkalemia is predominant in the diagnosis of arrhythmia (50%). Hyperkalemia varies according to the age groups. Cardiovascular diseases which have a risk of hypokalemia are arrhythmia, NSTEMI, and ventricular hypertrophy. The risk of hypokalemia and hyperkalemia increases at the arrhythmia diagnosis..

Copyright

© 2023 The Author(s)

Open Access

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

TY  - CONF
AU  - Linda Rosita
AU  - Mahdea Kasyiva
PY  - 2022
DA  - 2022/12/19
TI  - Profile of Potassium Serum in Coronary Heart Disease (CHD)
BT  - Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021)
PB  - Atlantis Press
SP  - 102
EP  - 107
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-048-0_12
DO  - 10.2991/978-94-6463-048-0_12
ID  - Rosita2022
ER  -